Search Results

Savonix , a global leader in digital cognitive health testing, and Fujitsu Connected Technologies Limited (FCNT) , one of the major smartphone manufacturers in Japan, unveiled Savonix Mobile–a digital cognitive testing app–on the Raku-Raku Smartphone F-42A. More than 4.6 million people in Japan are suffering from some form of dem

Savonix, a global leader in digital cognitive health testing, and Japanese trading company Mitani Sangyo Co, Ltd, announced yesterday a strategic partnership to provide Savonix’s digital cognitive assessment to all its employees over the age of 40

Savonix, a global leader in digital tests for cognitive health, announced that the company has published a research paper in the peer-reviewed medical journal Cognition, Brain, Behavior.

Savonix, a global leader in digital tests for cognitive health, today announced the appointment of Jillian Kwan-Jacobs as Chief Operating Officer effective October 18, 2019.

Savonix, a digital platform for real-time cognitive insights in clinical trials and clinical care, today announced that Dr. Mylea Charvat, CEO and Founder, will present at the following events during the most important week for healthcare investors on January 13-15, 2020, in San Francisco, CA.

Savonix announced it has been selected to join StartUp Health’s global network and portfolio of health innovation companies.

Savonix announced that the company will present at the upcoming MedTech Innovator 2019 Global Showcase at the Wilson Sonsini Goodrich & Rosati 27th Annual Medical Device Conference on Friday, June 21, 2019 in San Francisco, CA.

Savonix, a global leader in digital tests for cognitive health, and Bayer’s Consumer Health Division today announced a partnership agreement to work together to validate the effects of Bayer’s multivitamin supplement Berocca in the Malaysian market.

Savonix, a global leader in cognitive health, today announced the successful completion of $9.6M in Series A extension financing, bringing the total round to $14.7M.

Savonix announced that Dr. Mylea Charvat, CEO and Founder, will present at the Digital Medicine & Medtech Showcase ™ 2018 Conference to be held January 8-10, 2018 in San Francisco, CA.